{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:43:22Z","timestamp":1783691002551,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijrobp.2024.10.020","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T06:42:22Z","timestamp":1729665742000},"page":"1000-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reduced-dose Radiation Therapy for Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Multi-Institutional Prospective Study (KROG 16-18)"],"prefix":"10.1016","volume":"121","author":[{"given":"Seung Hyuck","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong In","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-1133","authenticated-orcid":false,"given":"Keun-Yong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.10.020_bib0001","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0002","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","article-title":"The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance","volume":"127","author":"Zucca","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0003","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0004","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4251\/wjgo.v13.i10.1453","article-title":"Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma","volume":"13","author":"Qu\u00e9ro","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0005","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0006","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdl468","article-title":"Role of radiation therapy in the treatment of stage I\/II mucosa-associated lymphoid tissue lymphoma","volume":"18","author":"Tsai","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/annonc\/mdn668","article-title":"Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy","volume":"20","author":"Gobbi","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0008","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","article-title":"Long-term results of stomach-conserving therapy in gastric MALT lymphoma","volume":"87","author":"Vrieling","year":"2008","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0009","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2008.03.012","article-title":"Radiotherapy for 41 patients with stages I and II MALT lymphoma: A retrospective study","volume":"87","author":"Yamashita","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0010","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0011","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/annonc\/mdx025","article-title":"Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma","volume":"28","author":"Teckie","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0012","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2015.08.029","article-title":"Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up","volume":"117","author":"Ruskon\u00e9-Fourmestraux","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0013","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1182\/bloodadvances.2020003992","article-title":"Involved-site radiotherapy for helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients","volume":"5","author":"Yahalom","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0014","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.3748\/wjg.v19.i36.6062","article-title":"Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"19","author":"Kim","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000339497","article-title":"A prospective analysis of efficacy and long-term outcome of radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma","volume":"86","author":"Okada","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0016","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0017","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijrobp.2019.02.002","article-title":"Outcomes after reduced-dose intensity modulated radiation therapy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma","volume":"104","author":"Pinnix","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0018","article-title":"Comparable efficacy of reduced dose radiation Therapy for the treatment of early stage gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue","volume":"6","author":"Saifi","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0019","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S2352-3026(24)00133-9","article-title":"Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial","volume":"11","author":"Gunther","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the international lymphoma radiation oncology group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0021","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","article-title":"Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma","volume":"52","author":"Copie-Bergman","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0022","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","article-title":"Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: A retrospective, multi-centre, international extranodal lymphoma study group study","volume":"24","author":"Wirth","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0023","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ijrobp.2020.11.070","article-title":"A prospective trial of radiation therapy efficacy and toxicity for localized mucosa-associated lymphoid tissue (MALT) lymphoma","volume":"109","author":"Fang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): A randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0025","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/cancers14174274","article-title":"Prospective study of 4 Gy radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma (FORMAL)","volume":"14","author":"Park","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0026","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5045\/br.2020.2020174","article-title":"Radiotherapy for non-gastric intestinal versus gastric MALT lymphoma: A comparison of treatment outcomes","volume":"55","author":"Watanabe","year":"2020","journal-title":"Blood Res"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0027","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2015.01.040","article-title":"Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent","volume":"92","author":"Teckie","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.020_bib0028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clml.2019.10.006","article-title":"18F-FDG PET\/CT or PET role in MALT lymphoma: an open issue not yet solved\u2014a critical review","volume":"20","author":"Albano","year":"2020","journal-title":"Clin Lymphoma, Myeloma Leuk"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624035132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624035132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:04Z","timestamp":1740134824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624035132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0360301624035132"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.020","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced-dose Radiation Therapy for Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Multi-Institutional Prospective Study (KROG 16-18)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}